Contrato Suministro Comprimidos Antimicrobianos
QUE ES NECESARIO CUBRIR DESABASTECIMIENTO DE CENABAST Y ADQUIRIR LO QUE ESTA NO ENTREGA
21 oferente(s) participaron en esta licitación. El detalle de quién compitió y con qué oferta está en el registro oficial de Mercado Público.
Ver oferentes en Mercado Público →| Código | Fecha | Proveedor | Monto |
|---|---|---|---|
| 1514-1830-SE15 | 29-05-2015 | Aventis Pharma Holding Gmbh | $908.922 |
| 1514-1847-SE15 | 29-05-2015 | Pfizer Chile S.A. | $777.546 |
| 1514-1846-SE15 | 29-05-2015 | Pfizer Chile S.A. | $1.633.746 |
| 1514-1826-SE15 | 29-05-2015 | Glaxosmithkline Chile Farmaceutica Limitada | $268.328 |
| 1514-1827-SE15 | 29-05-2015 | Opko Chile S.A. | $121.380 |
| 1514-1828-SE15 | 29-05-2015 | Laboratorio Chile S.A. | $126.429 |
| 1514-1829-SE15 | 29-05-2015 | Aventis Pharma Holding Gmbh | $130.900 |
| 2138-252-SE15 | 18-05-2015 | Winpharm SpA | $50.575 |
| 2137-195-SE15 | 06-05-2015 | Opko Chile S.A. | $70.686 |
| 2137-198-SE15 | 06-05-2015 | Laboratorio Chile S.A. | $29.801 |
| 1514-1335-SE15 | 24-04-2015 | Laboratorio Silesia S.A. | $66.640 |
| 1514-1002-SE15 | 01-04-2015 | Aventis Pharma Holding Gmbh | $902.139 |
| 1514-1048-SE15 | 01-04-2015 | Opko Chile S.A. | $94.605 |
| 2048-875-SE15 | 30-03-2015 | Aventis Pharma Holding Gmbh | $196.350 |
| 1514-966-SE15 | 30-03-2015 | Glaxosmithkline Chile Farmaceutica Limitada | $552.969 |
| 2137-107-SE15 | 18-03-2015 | Winpharm SpA | $104.720 |
| 1514-721-SE15 | 06-03-2015 | Opko Chile S.A. | $189.210 |
| 2048-580-SE15 | 02-03-2015 | Instituto Sanitas S.A. | $142.800 |
| 1663-167-SE15 | 18-02-2015 | Opko Chile S.A. | $424.116 |
| 2048-306-SE15 | 30-01-2015 | Instituto Sanitas S.A. | $142.800 |
| 2048-304-SE15 | 30-01-2015 | Aventis Pharma Holding Gmbh | $1.288.770 |
| 1514-254-SE15 | 23-01-2015 | Aventis Pharma Holding Gmbh | $881.790 |
| 2137-25-SE15 | 14-01-2015 | Laboratorio Silesia S.A. | $116.025 |
| 1514-71-SE15 | 07-01-2015 | Pfizer Chile S.A. | $162.078 |
| 1514-57-SE15 | 07-01-2015 | Aventis Pharma Holding Gmbh | $1.132.761 |
| 1663-1235-SE14 | 22-12-2014 | Opko Chile S.A. | $80.920 |
| 1663-1225-SE14 | 22-12-2014 | Laboratorio Chile S.A. | $71.400 |
| 1514-4422-SE14 | 12-12-2014 | Glaxosmithkline Chile Farmaceutica Limitada | $187.830 |
| 1514-4455-SE14 | 12-12-2014 | Aventis Pharma Holding Gmbh | $65.450 |
| 2137-539-SE14 | 09-12-2014 | Laboratorio Silesia S.A. | $44.625 |
| 2137-520-SE14 | 05-12-2014 | Winpharm SpA | $73.304 |
| 2137-521-SE14 | 05-12-2014 | Winpharm SpA | $68.663 |
| 1514-4268-SE14 | 01-12-2014 | Laboratorio Silesia S.A. | $183.260 |
| 2048-2855-SE14 | 05-11-2014 | Winpharm SpA | $50.575 |
| 1514-3567-SE14 | 13-10-2014 | Laboratorio Chile S.A. | $18.207 |
| 1514-3509-SE14 | 10-10-2014 | Glaxosmithkline Chile Farmaceutica Limitada | $53.666 |
| 2137-396-SE14 | 07-10-2014 | Winpharm SpA | $104.720 |
| 2048-2536-SE14 | 29-09-2014 | Opko Chile S.A. | $212.058 |
| 1663-869-SE14 | 11-09-2014 | Laboratorio Silesia S.A. | $435.540 |
| 1663-886-SE14 | 11-09-2014 | Aventis Pharma Holding Gmbh | $904.400 |
| 1663-892-SE14 | 11-09-2014 | Opko Chile S.A. | $434.350 |
| 1514-3151-SE14 | 08-09-2014 | Laboratorio Silesia S.A. | $66.640 |
| 1514-3056-SE14 | 01-09-2014 | Laboratorio Chile S.A. | $18.207 |
| 507428-214-SE14 | 01-09-2014 | Laboratorio Silesia S.A. | $104.125 |
| 1514-2836-SE14 | 18-08-2014 | Laboratorio Silesia S.A. | $66.640 |
| 1514-2750-SE14 | 08-08-2014 | Glaxosmithkline Chile Farmaceutica Limitada | $134.164 |
| 1663-655-SE14 | 11-07-2014 | Laboratorio Chile S.A. | $57.614 |
| 1663-656-SE14 | 11-07-2014 | Laboratorio Silesia S.A. | $291.550 |
| 2048-1636-SE14 | 30-06-2014 | Instituto Sanitas S.A. | $142.800 |
| 1514-1824-SE14 | 23-05-2014 | Laboratorio Silesia S.A. | $52.360 |
| 1663-477-SE14 | 10-05-2014 | Laboratorio Chile S.A. | $89.250 |
| 2048-1079-SE14 | 29-04-2014 | Winpharm SpA | $66.640 |
| 2048-1092-SE14 | 29-04-2014 | Instituto Sanitas S.A. | $71.400 |
| 1514-1332-SE14 | 17-04-2014 | Glaxosmithkline Chile Farmaceutica Limitada | $214.663 |
| 2137-117-SE14 | 08-04-2014 | Winpharm SpA | $105.558 |
| 1514-1047-SE14 | 28-03-2014 | Glaxosmithkline Chile Farmaceutica Limitada | $120.748 |
| 2137-76-SE14 | 10-03-2014 | Farmaceutica Caribean SpA | $7.030 |
| 2137-77-SE14 | 10-03-2014 | Farmaceutica Caribean SpA | $52.622 |
Fuente original:ficha mercadopublico.cl
